EUVIMEDEUVIMED entdecken
Crossref

Serum CA125 as a biomarker for dysmenorrhea in adenomyosis

Ying Tang, Ming-Bo Wen, Ru-Mei Xiang, Ming-Tao Yang, Bin Shu, Fan Xu, Jun Li, Hui-Quan Hu, Qiuling Shi

International Journal of Gynecology & Obstetrics · 2023-10 · 163 (1) · 131-139

DOI: 10.1002/ijgo.14832 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 12.05.2023. Verfasst von Ying Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Adenomyosis. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Bureau of Science and Technology Nanchong City, State Key Laboratory of Scientific and Engineering Computing, General Program of National Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To explore the association between CA125 and dysmenorrhea in adenomyosis, and the factors affecting CA125 in adenomyosis.

Methods

Patients were grouped a the presence of dysmenorrhea. The receiver operating characteristic (ROC) curve was applied to assess the utility of CA125 for dysmenorrhea. Binary logistic regression was employed to identify the factors associating dysmenorrhea and CA125 level.

Results

Patients in the dysmenorrhea group had higher CA125 levels than those in the non‐dysmenorrhea group. For those with dysmenorrhea, CA125 levels of diffuse subtype group were higher than those of the focal subtype group. The CA125 level of 35 U/mL was validated as the optimal cut‐point for dysmenorrhea in ROC curves. Compared with patients whose CA125 was 35 U/mL or less, those with CA125 levels greater than 35 U/mL were more likely to have dysmenorrhea. Thereafter, the multiple regression analysis showed that adenomyotic lesion volume was positively correlated with CA125 level in the total cohort and subtype groups, while age was negatively correlated with CA125 level in the total cohort and diffuse subtype.

Conclusions

The pathogenesis of adenomyosis is not clear. CA125 was associated with dysmenorrhea in adenomyosis, and, furthermore, CA125 level is positively correlated with the severity of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenomyosisFemaleHumansDysmenorrheaCA-125 AntigenLogistic Models

Stichwörter der Autor:innen

CA125adenomyosisassociationdysmenorrheainflammationpathogenesis

Substanzen

CA-125 Antigen

Autor:innen und Institutionen

  • State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, China.
  • Department of Obstetrics and Gynecology, The Affiliated Nanchong Central Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
  • School of Public Health and Management, Chongqing Medical University, Chongqing, China.

Förderung

  • Bureau of Science and Technology Nanchong City
  • State Key Laboratory of Scientific and Engineering Computing
  • General Program of National Natural Science Foundation

Zitieren

APA

Tang, Y., Wen, M. B., Xiang, R. M., Yang, M. T., Shu, B., Xu, F., Li, J., Hu, H. Q., & Shi, Q. (2023). Serum CA125 as a biomarker for dysmenorrhea in adenomyosis. International Journal of Gynecology & Obstetrics, 163(1), 131-139. https://doi.org/10.1002/ijgo.14832

Vancouver

Tang Y, Wen MB, Xiang RM, Yang MT, Shu B, Xu F, et al. Serum CA125 as a biomarker for dysmenorrhea in adenomyosis. International Journal of Gynecology & Obstetrics. 2023;163(1):131-139. doi:10.1002/ijgo.14832

BibTeX
@article{Tang2023,
  author = {Tang, Ying and Wen, Ming-Bo and Xiang, Ru-Mei and Yang, Ming-Tao and Shu, Bin and Xu, Fan and Li, Jun and Hu, Hui-Quan and Shi, Qiuling},
  title = {Serum CA125 as a biomarker for dysmenorrhea in adenomyosis},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2023},
  volume = {163},
  number = {1},
  pages = {131--139},
  doi = {10.1002/ijgo.14832}
}
Kostenlos starten →